Home > Boards > US Listed > Biotechs > AVANIR PHARMACEUTICALS (AVNR)

Wish I'd bought more on the dip. Go AVNR!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BHNM Member Profile
 
Followed By 0
Posts 149
Boards Moderated 0
Alias Born 04/29/10
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 7/22/2014 4:33:32 PM
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder "PR Newswire (US)" - 7/21/2014 9:15:00 AM
Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study "PR Newswire (US)" - 7/16/2014 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/10/2014 7:42:09 PM
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association I... "PR Newswire (US)" - 6/30/2014 7:22:00 PM
Avanir Pharmaceuticals Announces Three Data Presentations Related to AVP-825 for the Acute Treatment of Migraine at the Ameri... "PR Newswire (US)" - 6/24/2014 8:30:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 6/10/2014 4:10:20 PM
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral... "PR Newswire (US)" - 6/10/2014 4:00:00 AM
Avanir Pharmaceuticals Announces Multiple Data Presentations Related to Pseudobulbar Affect (PBA) Prevalence and Treatment at... "PR Newswire (US)" - 5/30/2014 9:00:00 AM
Avanir Pharmaceuticals to Participate in Two Conferences in June "PR Newswire (US)" - 5/28/2014 9:00:00 AM
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patie... "PR Newswire (US)" - 5/27/2014 9:00:00 AM
Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher - Tale of the Tape "Zacks" - 5/15/2014 9:18:00 AM
QLT Inc. (QLTI) Falls: Stock Goes Down 9.13% - Tale of the Tape "Zacks" - 5/14/2014 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 5/9/2014 4:33:21 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2014 5:25:20 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/7/2014 4:50:09 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/7/2014 2:31:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/6/2014 4:31:14 PM
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results "PR Newswire (US)" - 5/6/2014 4:01:00 PM
Avanir Pharmaceuticals to Participate in Two Conferences in May "PR Newswire (US)" - 5/1/2014 4:00:00 PM
Fed Shows Confidence in Market with Cut in Bond Buying Stimulus "PR Newswire (US)" - 5/1/2014 7:31:00 AM
Fed Shows Confidence in Market with Cut in Bond Buying Stimulus "PR Newswire (US)" - 5/1/2014 7:31:00 AM
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026 "PR Newswire (US)" - 4/30/2014 3:04:00 PM
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Second Quarter Financial Results and Conference Call "GlobeNewswire Inc." - 4/29/2014 9:00:00 AM
Avanir Pharmaceuticals Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franc... "PR Newswire (US)" - 4/28/2014 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist